The supplier has advised that due to a global shortage of Skinoren active ingredient LEO Pharma have advised that supply will be discontinued until 2020.

Their current stock is expected to be exhausted during September 2019 and subsequent orders may not be fulfilled.

There is stock available in the supply chain presently, however once exhausted there will be no more as advised until 2020.

This is a non-funded medicine and there are alternatives available in the market for prescribers.

We thank you in anticipation of your ongoing support.

About The Author